285
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Influence of type of treatment on the well-being of Spanish patients with schizophrenia and their caregivers

, , , &
Pages 286-295 | Received 16 Feb 2011, Accepted 25 Jul 2011, Published online: 19 Sep 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Maju Mathews, Srihari Gopal, Isaac Nuamah, Ludger Hargarter, Adam J Savitz, Edward Kim, Wilson Tan, Bernardo Soares & Christoph U Correll. (2019) Clinical relevance of paliperidone palmitate 3-monthly in treating schizophrenia. Neuropsychiatric Disease and Treatment 15, pages 1365-1379.
Read now
Cristiana Montemagni, Tiziana Frieri & Paola Rocca. (2016) Second-generation long-acting injectable antipsychotics in schizophrenia: patient functioning and quality of life. Neuropsychiatric Disease and Treatment 12, pages 917-929.
Read now

Articles from other publishers (9)

Claudio Brasso, Silvio Bellino, Paola Bozzatello, Cristiana Montemagni, Marco Giuseppe Alberto Nobili, Rodolfo Sgro & Paola Rocca. (2023) Second Generation Long-Acting Injectable Antipsychotics in Schizophrenia: The Patient’s Subjective Quality of Life, Well-Being, and Satisfaction. Journal of Clinical Medicine 12:22, pages 6985.
Crossref
William Tak‐Lam Lo, Daniel Ki‐Yan Mak, Michael Ming‐Cheuk Wong, Oi‐Wah Chan, Eileena Mo‐Ching Chui, Dicky Wai‐Sau Chung, Glendy Suk‐Han Ip, Ka‐Shing Lau, Che‐Kin Lee, Jolene Mui, Ka‐Lok Tam, Samson Tse & Kwong‐Lui Wong. (2021) Achieving better outcomes for schizophrenia patients in Hong Kong: Strategies for improving treatment adherence. CNS Neuroscience & Therapeutics 27:S1, pages 12-19.
Crossref
Seon-Cheol Park, Mi Young Choi, Jina Choi, Eunjung Park, Ha Jin Tchoe, Jae Kyung Suh, Young Hoon Kim, Seung Hee Won, Young-Chul Chung, Kyung-Yeol Bae, Sang-Kyu Lee, Chan Mi Park & Seung-Hwan Lee. (2018) Comparative Efficacy and Safety of Long-acting Injectable and Oral Second-generation Antipsychotics for the Treatment of Schizophrenia: A Systematic Review and Meta-analysis. Clinical Psychopharmacology and Neuroscience 16:4, pages 361-375.
Crossref
J.I. Arraras, B. Ibañez, I. Basterra, N. Pereda, M. Martin & S. Iribarren. (2018) Determinants of Quality of Life in Spanish outpatients with schizophrenia spectrum disorders. The European Journal of Psychiatry 32:3, pages 113-121.
Crossref
Taishiro Kishimoto, Katsuhiko Hagi, Masahiro Nitta, Stefan Leucht, Mark Olfson, John M Kane & Christoph U Correll. (2018) Effectiveness of Long-Acting Injectable vs Oral Antipsychotics in Patients With Schizophrenia: A Meta-analysis of Prospective and Retrospective Cohort Studies. Schizophrenia Bulletin 44:3, pages 603-619.
Crossref
Miguel Bernardo, Fernando Cañas, Berta Herrera & Marta García Dorado. (2017) Adherence predicts symptomatic and psychosocial remission in schizophrenia: Naturalistic study of patient integration in the community. Revista de Psiquiatría y Salud Mental (English Edition) 10:3, pages 149-159.
Crossref
Miguel Bernardo, Fernando Cañas, Berta Herrera & Marta García Dorado. (2017) La adherencia predice la remisión sintomática y psicosocial en esquizofrenia: estudio naturalístico de la integración de los pacientes en la comunidad. Revista de Psiquiatría y Salud Mental 10:3, pages 149-159.
Crossref
Georgia L. Stevens, Gail Dawson & Jacqueline Zummo. (2015) Clinical benefits and impact of early use of long‐acting injectable antipsychotics for schizophrenia. Early Intervention in Psychiatry 10:5, pages 365-377.
Crossref
Shaloo Gupta, Gina Isherwood, Kevin Jones & Kristel Van Impe. (2015) Assessing health status in informal schizophrenia caregivers compared with health status in non-caregivers and caregivers of other conditions. BMC Psychiatry 15:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.